Report overview
Beta thalassemia is a condition in which the production of hemoglobin reduces. Hemoglobin is the iron-containing protein in red blood cells that carries oxygen to cells throughout the body. Risk factors associated with thalassemia are family history and ancestry. The types of beta thalassemia depends on the severity. Beta thalassemia minor is also called beta thalassemia trait. People with beta thalassemia minor may have mild anemia; however, people with beta thalassemia intermedia have moderately severe anemia. People with Cooley's anemia, also called beta thalassemia major, experience severe symptoms and life-threatening anemia.
This report aims to provide a comprehensive presentation of the global market for Beta Thalassemia Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta Thalassemia Testing. This report contains market size and forecasts of Beta Thalassemia Testing in global, including the following market information:
Global Beta Thalassemia Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Beta Thalassemia Testing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Kits Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Beta Thalassemia Testing include MedGenome, 3B BlackBio Biotech India Limited, Bio-Rad Laboratories, Inc., ViennaLab Diagnostics, Thermo Fisher Scientific Inc., PerkinElmer Inc., BioMedomics, Inc., Asper Biogene and Tosoh Bioscience, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Beta Thalassemia Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Beta Thalassemia Testing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Beta Thalassemia Testing Market Segment Percentages, by Type, 2023 (%)
Kits
Consumables
Global Beta Thalassemia Testing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Beta Thalassemia Testing Market Segment Percentages, by Application, 2023 (%)
Hospitals and Specialty Clinics
Diagnostics Centers
Others
Global Beta Thalassemia Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Beta Thalassemia Testing Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Beta Thalassemia Testing revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Beta Thalassemia Testing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
MedGenome
3B BlackBio Biotech India Limited
Bio-Rad Laboratories, Inc.
ViennaLab Diagnostics
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
BioMedomics, Inc.
Asper Biogene
Tosoh Bioscience, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Beta Thalassemia Testing, market overview.
Chapter 2: Global Beta Thalassemia Testing market size in revenue.
Chapter 3: Detailed analysis of Beta Thalassemia Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Beta Thalassemia Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
